So 5% of 3.7M and 1 % of the 6.3M with a 10 x PE ~ $9.25 AUD/share
And that is ONLY taking into account the actual sales of Sofdra.
The REAL value I believe is in the seamless telehealth, direct-to-consumer platform. This is the jewel in the crown! That is what a buyer is really going to be wanting, and they just happen to get a successful product along with it!
Ann: Botanix $40 Million Capital Raising for Sofdra Rollout, page-313
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.3¢ |
Change
-0.003(0.85%) |
Mkt cap ! $573.5M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 30.5¢ | 28.3¢ | $2.146M | 7.391M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 193712 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 631087 | 18 |
View Market Depth
| Last trade - 14.01pm 17/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |